Publications

Prognostic impact of Remote Dielectric Sensing value following TAVR

ReDS system might be a promising non-invasive tool to predict mortality and readmission following TAVR

Publication Name: Heart and Vessels
Lead Author: Teruhiko Imamura
Year: 2023

Efficacy of remote dielectric sensing (ReDS) in the prevention of heart failure rehospitalizations: a meta-analysis

Seven studies compiled and 985 patients analyzed, found that ReDS monitoring decreases the odds of HF readmission within 1 & 3 months of hospitalization

Publication Name: Journal of Community Hospital Internal Medicine Perspectives
Lead Author: Yasar Sattar
Year: 2021

Patient monitoring across the spectrum of heart failure disease management 10 years after the CHAMPION trial

Reviews ReDS™ technology (and CardioMEMS) for providing accurate, absolute, and actionable congestion measurement and guiding patients management in various settings across the continuum of care

Publication Name: ESC Heart Failure
Lead Author: William T. Abraham
Year: 2021

Validation of remote dielectric sensing (ReDS™) technology for quantification of lung fluid status: Comparison to high resolution chest computed tomography in patients with and without acute heart failure

High correlation between ReDS and CT, the scientific gold standard for lung fluid measurement 

Publication Name: International Journal of Cardiology
Lead Author: Offer Amir
Year: 2016

Association between Lung Fluid Levels Estimated by Remote Dielectric Sensing Values and Invasive Hemodynamic Measurements

Good correlation between ReDS™ and PCWP. ReDS can be a helpful tool in estimating intra-cardiac pressures in heart failure patients.

Publication Name: Journal of Clinical Medicine
Lead Author: Teruhiko Imamura
Year: 2022

Relationship Between Noninvasive Assessment of Lung Fluid Volume and Invasively Measured Cardiac Hemodynamics

Lung fluid content, as measured by ReDS™, correlates well with pulmonary arterial wedge pressure (PAWP). The high sensitivity and specificity and especially the high negative predictive value make ReDS a reliable noninvasive tool at the point of care, to rule out elevated PAWP in patients with heart failure and to help with medical management of patients with heart failure.

Publication Name: Journal of the American Heart Association
Lead Author: Nir Uriel
Year: 2018

Early use of remote dielectric sensing after hospitalization to reduce heart failure readmissions

Use of ReDS POC testing at a post-discharge outpatient clinic for optimization of GDMT medications resulted in 79% decrease in 30-day CV readmission rate. Real world data of 220 patients from Mount Sinai hospital. 

Publication Name: ESC Heart Failure
Lead Author: Anuradha Lala
Year: 2021

Effect of the Remote Dielectric Sensing Vest on Reducing Heart Failure Admissions

ReDS based treatment at outpatient setting led to a significant reduction in unexpected hospitalization for HF. Real world data from Rochester Regional, NY.

Publication Name: Poster HFSA
Lead Author: Sumon Roy
Year: 2021

Reducing Heart Failure Rehospitalization Utilizing ReDS™ Technology

ReDS technology use post HF hospitalization in the outpatient HF clinic significantly reduced 30-day rehospitalization rate compared to general HF population without use of ReDS technology. Real world data from Einstein hospital, PA.

Publication Name: Abstract and Presentation, HFSA
Lead Author: Donna Moser
Year: 2019

Noninvasive Assessment of Lung Fluid Volume by Remote Dielectric Sensing (ReDS™) Technology to Reduce Rate of Heart Failure Readmissions

The adoption of ReDS™ device into in-hospital management of patients admitted for ADHF was shown to decrease 30-day all-cause readmission rate. Real world data of 416 patients from St. Barnabas, NJ.

Publication Name: Poster and Webinar HFSA
Lead Author: Gary Rogal
Year: 2021

A Novel Therapeutic Strategy: Remote Dielectric Sensing-Guided Management of Pulmonary Congestion

A case study of HF patient received ReDS-guided management from admission to discharge. 

Publication Name: Journal of Cardiology Cases
Lead Author: Akira Oshima
Year: 2021

A Novel Approach to Monitoring Pulmonary Congestion in Heart Failure: Initial Animal and Clinical Experiences Using Remote Dielectric Sensing Technology 

Early feasibility study in ADHF patients combined with experience from preclinical setting and healthy patients showed that ReDS technology can track changes in lung fluid. 

Publication Name: Congest Heart Fail 
Lead Author: Offer Amir
Year: 2013

The Use of The ReDS Noninvasive Lung Fluid Monitoring System to Assess Readiness for Discharge In Patients Hospitalized With Acute Heart Failure: A Pilot Study 

ReDS testing demonstrated that 32% of HF patients deemed ready for discharge have clinically significant residual lung congestion (ReDS >39%) which was associated with a higher risk of 30-day readmission. 

Publication Name:
 Heart & Lung 
Lead Author: Daniel Bensimhon 
Year: 2021

Sensible Medical Vest Experience at Rochester Regional Health System  

Using ReDS guided management prior to discharge demonstrated a significant reduction in readmission rate in comparison to historical control.

Publication Name:
 Abstract and Presentation, HFSA 
Lead Author: Scott C. Feitell
Year: 2018

Remote dielectric sensing for detecting pulmonary edema in the emergency department 

A prospective pilot study assessing the accuracy of ReDS to detect pathologic lung fluid in ED undifferentiated dyspneic patients.

Publication Name:
 American Journal of Emergency Medicine  
Lead Author: Zubaid Rafique,   
Year: 2022

Assessing HF in the Emergency Department  

Initial data suggesting that ReDS reading in the emergency department predicts 30-day outcome and can be used to identify patients who can be safely discharged versus those who require more intensive treatment.

Publication Name:
 Abstract and Presentation, HFSA   
Lead Author: Christopher Chien
Year: 2019

ReDS across the Continuum of Care: How to initiate your Heart Failure Program   

A visiting nurse program, employing ReDS technology and a specifically designed diuretic protocol to assess and treat HF patients, improved the readmission rate of a community hospital.

Publication Name:
 Abstract and Presentation, HFSA   
Lead Author: Daniel Bensimhon
Year: 2018

Geisinger Caring Experience 

Utilize ReDS™ technology to assess volume status at the community for reduction in readmission rate.

Publication Name:
 Presented HFSA    
Lead Author: Sanjay Doddamani
Year: 2017

ReDS Monitoring In Conjunction With Multifaceted Team Reduces Readmissions From Skilled Nursing Facilities  

Use of ReDS guided management at skilled nurse facilities assisted in reducing all-cause readmission rate. Real world data from Allegheny, PA. 

Publication Name:
 Abstract and Poster HFSA     
Lead Author: A Hadi  
Year: 2020

Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE-HF trial  

Astra Zeneca funded trial used ReDS as a biomarker to evaluate Dapagliflozin effect on lung fluid.

Publication Name: Diabetes Obes Metab.      
Lead Author: Michael E. Nassif  
Year: 2021

Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial   

 Bayer clinical trial used ReDS as a biomarker to evaluate V1a/V2 antagonist effect on lung fluid.

Publication Name:
 Journal of Cardiac Failure       
Lead Author: Steven R.Goldsmith   
Year: 2021

A Descriptive Analysis of ReDS Technology Across the Continuum of Care     

ReDS technology used across the continuum of care revealed residual, clinically-significant, volume overload in patients at all points of care, (emergency department, discharge, heart failure clinic, primary care and home). 605 patients from Triad Health Network, NC. 

Publication Name: Abstract and Presentation, HFSA        
Lead Author: Daniel Bensimhon    
Year: 2019

Sensible Medical Innovations Lung fluid status monitor allows reducing readmission rate of heart failure patients

A prospective, randomized, controlled, multi-center trial which compared ReDS-guided treatment at home vs. standard of care management.

Publication Name:
 Presented at HFSA        
Lead Author: NA    
Year: 2019

Evaluation of remote dielectric sensing (ReDS) technology-guided therapy for decreasing heart failure re-hospitalizations 

Multi-center home study with remote ReDS guided management showed reduction in HF readmissions in comparison to pre- and post-study periods. 

Publication Name: International Journal of Cardiology         
Lead Author: Offer Amir     
Year: 2017

Validation of Remote Dielectric Sensing (ReDS) in Monitoring Adult Patients Affected by COVID-19 Pneumonia  

A pilot study showing that ReDS can track changes in lung involvement in COVID-19 patients.

Publication Name: Diagnostics          
Lead Author:  Federico Mei     
Year: 2021

Heart Failure Collaboratory Statement on Remote Monitoring and Social Distancing in the Landscape of COVID-19   

Guiding principles for HF remote monitoring during and following the COVID-19 crisis, recommended on adoption of remote patient monitoring technologies like ReDS technology, to provide better assessment of HF clinical status while maintaining social distancing.

Publication Name: JACC: Heart Failure           
Lead Author:  William T. Abraham     
Year: 2020

Relationship Between Body Posture and Lung Fluid Volume Assessed Using a Novel Noninvasive Remote Dielectric Sensing System    

A proof-of-concept study in healthy volunteers investigating the relationship between body posture and lung fluid by ReDS.

Publication Name:
 Published           
Lead Author: Teruhiko Imamura      
Year: 2021